{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:06:01Z","timestamp":1789909561729,"version":"4.0.1"},"reference-count":41,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2011,4,9]]},"published-print":{"date-parts":[[2011,10]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To estimate the loss of quality of life and cost of treatment associated with genital warts seen in sexual health clinics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional questionnaire study and case note review of individuals with genital warts, carried out in eight sexual health clinics in England and Northern Ireland. Individuals with genital warts attending the participating clinics were invited to take part in the questionnaire study. 895 participants were recruited. A separate sample of 370 participants who had attended a participating clinic with a first visit for a first or recurrent episode of genital warts between April and June 2007 was included in the case note review. Quality of life was measured using the EQ-5D questionnaire and the cost of an episode of care was derived from the case note review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The weighted mean EQ-5D index score was 0.87 (95% CI 0.85 to 0.89). The weighted mean disutility was 0.056 (95% CI 0.038 to 0.074). The estimated mean loss of quality-adjusted life-years associated with an episode of genital warts was 0.018 (95% CI 0.0079 to 0.031), equivalent to 6.6\u2005days of healthy life lost per episode. The weighted mean cost per episode of care was \u00a394 (95% CI \u00a384 to \u00a3104), not including the cost of a sexually transmitted infection screen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Genital warts have a substantial impact on the health service and the individual. This information can be utilised for economic evaluation of human papillomavirus vaccination.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2011-050073","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T03:07:18Z","timestamp":1307070438000},"page":"458-463","source":"Crossref","is-referenced-by-count":90,"title":["The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK"],"prefix":"10.1136","volume":"87","author":[{"given":"S C","family":"Woodhall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Jit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Soldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Kinghorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Gilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J N","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2011,6,2]]},"reference":[{"key":"2024051319034080000_87.6.458.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a2552"},{"key":"2024051319034080000_87.6.458.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a769"},{"key":"2024051319034080000_87.6.458.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641"},{"key":"2024051319034080000_87.6.458.4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605747"},{"key":"2024051319034080000_87.6.458.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3493"},{"key":"2024051319034080000_87.6.458.6","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","article-title":"Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients","volume":"37","author":"Brown","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2024051319034080000_87.6.458.7","unstructured":"Health Protection Agency STI Annual Data Tables. Table 2: Total number of STI diagnoses and other episodes of care seen at genitourinary medicine clinics, UK and England 2000\u20132009. http:\/\/www.hpa.org.uk\/web\/HPAweb&HPAwebStandard\/HPAweb_C\/1203348026613 (accessed Aug 2010)."},{"key":"2024051319034080000_87.6.458.8","unstructured":"Woodhall SC Lacey CJN Wikstrom A . European Guidelines (IUSTI\/WHO) on the management of anogenital warts. Poster presentation at the 25th International Papillomavirus Conference; 8\u201314 May 2009. Malm\u00f6, Sweden, 2009."},{"key":"2024051319034080000_87.6.458.9","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.048421"},{"key":"2024051319034080000_87.6.458.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.125"},{"key":"2024051319034080000_87.6.458.11","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2009.037788"},{"key":"2024051319034080000_87.6.458.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70225-5"},{"key":"2024051319034080000_87.6.458.13","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.029512"},{"key":"2024051319034080000_87.6.458.14","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181a74c2c"},{"key":"2024051319034080000_87.6.458.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a2186"},{"key":"2024051319034080000_87.6.458.16","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.032755"},{"key":"2024051319034080000_87.6.458.17","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2024051319034080000_87.6.458.18","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N"},{"key":"2024051319034080000_87.6.458.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7133.736"},{"key":"2024051319034080000_87.6.458.20","unstructured":"Curtis L . Unit costs of health and social care. 2009. http:\/\/www.pssru.ac.uk\/uc\/uc2009contents.htm (accessed Jul 2010)."},{"key":"2024051319034080000_87.6.458.21","unstructured":"NHS. NHS electronic drug tariff. http:\/\/www.ppa.org.uk\/ppa\/edt_intro.htm (accessed Aug 2010)."},{"key":"2024051319034080000_87.6.458.22","unstructured":"Joint Formulary Committee. British National Formulary. 59th edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2010."},{"key":"2024051319034080000_87.6.458.23","unstructured":"Pearce V Grant A Adams E . Technical document\u2014Phase 1 methodology of the proposed integrated sexual health pricing and currencies for London. Community Sexual Health Services. London: Pathway Analytics, 2009."},{"key":"2024051319034080000_87.6.458.24","unstructured":"BASHH Standards for the Management of Sexually Transmitted Infections. London: British Association of Sexual Health and HIV, 2010. http:\/\/www.bashh.org\/guidelines (accessed Aug 2010)."},{"key":"2024051319034080000_87.6.458.25","first-page":"A4140","article-title":"Long-term quality of life effects of genital warts\u2014a follow-study","volume":"57","author":"Mortensen","year":"2010","journal-title":"Dan Med Bull"},{"key":"2024051319034080000_87.6.458.26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00007435-199301000-00003","article-title":"Physical and psychological effects of anogenital warts on female patients","volume":"20","author":"Persson","year":"1993","journal-title":"Sex Transm Dis"},{"key":"2024051319034080000_87.6.458.27","unstructured":"Data from the GU Medicine Clinical Activity Dataset (GUMCAD). London: Health Protection Agency, 2010."},{"key":"2024051319034080000_87.6.458.28","unstructured":"Myers E Green S Lipkus I . Patient preferences for health states related to HPV infection: visual analogue scales versus time trade-off elicitation. Proceedings of the 21st International Papillomavirus Conference; 20\u201327 Feb 2004, Mexico City, Mexico, 2004."},{"key":"2024051319034080000_87.6.458.29","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X99972"},{"key":"2024051319034080000_87.6.458.30","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e318191a55e"},{"key":"2024051319034080000_87.6.458.31","doi-asserted-by":"publisher","DOI":"10.1086\/427557"},{"key":"2024051319034080000_87.6.458.32","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.033837"},{"key":"2024051319034080000_87.6.458.33","doi-asserted-by":"publisher","DOI":"10.1258\/0956462041558168"},{"key":"2024051319034080000_87.6.458.34","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.030999"},{"key":"2024051319034080000_87.6.458.35","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2009.040188"},{"key":"2024051319034080000_87.6.458.36","doi-asserted-by":"publisher","DOI":"10.1086\/375074"},{"key":"2024051319034080000_87.6.458.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.gyobfe.2006.12.010"},{"key":"2024051319034080000_87.6.458.38","unstructured":"Fiander A Cohet C . for the PasQual Study Team. Psychosocial impact of HPV-related diseases in men in the UK: the PasQual study. Proceedings of Eurogin 2010 Conference; 17\u201320 Feb 2010, Monte Carlo, Monaco, 2010."},{"key":"2024051319034080000_87.6.458.39","unstructured":"Fiander A Cohet C for the PasQual Study Team . Psychosocial impact of HPV-related diseases in women in the UK: the PasQual study. Proceedings of Eurogin 2010 Conference; 17\u201320 Feb 2010, Monte Carlo, Monaco, 2010."},{"key":"2024051319034080000_87.6.458.40","unstructured":"Drolet M Brisson M Maunsell E . Loss of quality of life associated with genital warts: a prospective 6-month study. Proceedings of Eurogin 2010 Conference; 17\u201320 Feb 2010, Monte Carlo, Monaco, 2010."},{"key":"2024051319034080000_87.6.458.41","unstructured":"Department of Health 2010\u20132011 National Tariff Information. London: Department of Health. http:\/\/data.gov.uk\/dataset\/payment-by-results-2010-11-national-tariff-information (accessed Aug 2010)."}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2011-050073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T02:11:01Z","timestamp":1715652661000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2011-050073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,2]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,9,13]]},"published-print":{"date-parts":[[2011,10]]}},"alternative-id":["10.1136\/sextrans-2011-050073"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2011-050073","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,2]]}}}